GlassScriptPhysician profile
Ami L Herbstrith
NPI 1336135995
$2,054.84
in general payments reported to CMS, 2019-2025
25 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $880 · 2020: $301 · 2021: $244 · 2023: $51.08 · 2024: $222 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $630.54 | 2019-2021 | |
| Gentleman Orthopedic Solutions | $251.30 | 2021-2025 | |
| Melinta Therapeutics, LLC | $190.53 | 2019-2021 | |
| Organogenesis INC. | $189.25 | 2019-2021 | |
| Smith+Nephew, INC. | $90.37 | 2019-2024 | Collagenase Santyl, Regranex |
| Kerecis Limited | $90.23 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Amgen INC. | $73.11 | 2025 | Krystexxa |
| Bioventus LLC | $51.65 | 2025 | Exogen Ultrasound Bone Healing System |
| Acera Surgical, INC. | $50.81 | 2019-2021 | |
| Treace Medical Concepts, INC. | $47.50 | 2025 | |
| Nevro Corp. | $47.13 | 2023-2024 | Senza |
| Angiodynamics, INC. | $44.40 | 2019 | |
| Abbvie INC. | $38.48 | 2021-2025 | |
| Boston Scientific Corporation | $35.50 | 2019-2024 | Patient Trial Kit |
| Horizon Therapeutics Plc | $28.74 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $28.68 | 2021-2025 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $26.53 | 2025 | |
| Zyla Life Sciences, INC. | $22.60 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.74 | 2023 | Jublia |
| Osiris Therapeutics INC. | $20.16 | 2019 | |
| Advanced Oxygen Therapy INC. | $18.57 | 2024 | Topical Oxygen Chamber For Extremities |
| Cumberland Pharmaceuticals, INC. | $16.95 | 2019 | |
| Orthofix Medical, INC. | $14.36 | 2019 | |
| Depuy Synthes Sales INC. | $13.51 | 2019 | |
| Sandoz INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami Herbstrith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.